Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koike, T.
Right arrow Articles by Yoshida, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koike, T.
Right arrow Articles by Yoshida, S.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 36, Issue 4 539-541, Copyright © 1987 by American Diabetes Association


ARTICLES

Preventive effect of monoclonal anti-L3T4 antibody on development of diabetes in NOD mice

T Koike, Y Itoh, T Ishii, I Ito, K Takabayashi, N Maruyama, H Tomioka and S Yoshida

We analyzed the surface phenotypes of infiltrated cells in pancreases of nonobese diabetic (NOD) mice with monoclonal antibodies to mouse lymphocytes. Most of the infiltrated cells were Thy1+ and Ly1+ T-lymphocytes, and most of them were L3T4+ helper T-lymphocyte subsets. To elucidate the role of L3T4+ T-lymphocytes in the development of insulitis and diabetes in NOD mice, we treated the animals with injections of monoclonal anti-L3T4 antibody. Administration of this antibody prevented the insulitis and diabetes in NOD mice. These results lead to conclusions that the L3T4+ helper T-lymphocytes may play an essential role in the pathogenesis of type I diabetes and that the manipulation of the OKT4+ (Leu3+) T-lymphocyte subset, the human homology of L3T4, with monoclonal antibodies may provide effective therapy for human type I diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. L.-T. Chang, S.-L. Chang, Y.-M. Lee, Y.-M. Chiang, D.-Y. Chuang, H.-K. Kuo, and W.-C. Yang
Cytopiloyne, a Polyacetylenic Glucoside, Prevents Type 1 Diabetes in Nonobese Diabetic Mice
J. Immunol., June 1, 2007; 178(11): 6984 - 6993.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. M. Kupfer, M. L. Crawford, K. Pham, and R. G. Gill
MHC-Mismatched Islet Allografts Are Vulnerable to Autoimmune Recognition In Vivo
J. Immunol., August 15, 2005; 175(4): 2309 - 2316.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Ogawa, J. F. List, J. F. Habener, and T. Maki
Cure of Overt Diabetes in NOD Mice by Transient Treatment With Anti-Lymphocyte Serum and Exendin-4
Diabetes, July 1, 2004; 53(7): 1700 - 1705.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Judkowski, C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D. B. Wilson
Identification of MHC Class II-Restricted Peptide Ligands, Including a Glutamic Acid Decarboxylase 65 Sequence, that Stimulate Diabetogenic T Cells from Transgenic BDC2.5 Nonobese Diabetic Mice
J. Immunol., January 15, 2001; 166(2): 908 - 917.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Kanagawa, J. Shimizu, and B. A. Vaupel
Thymic and Postthymic Regulation of Diabetogenic CD8 T Cell Development in TCR Transgenic Nonobese Diabetic (NOD) Mice
J. Immunol., May 15, 2000; 164(10): 5466 - 5473.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Poulin and K. Haskins
Induction of Diabetes in Nonobese Diabetic Mice by Th2 T Cell Clones from a TCR Transgenic Mouse
J. Immunol., March 15, 2000; 164(6): 3072 - 3078.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. T. Cantorna
Vitamin D and Autoimmunity: Is Vitamin D Status an Environmental Factor Affecting Autoimmune Disease Prevalence?
Experimental Biology and Medicine, March 1, 2000; 223(3): 230 - 233.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
E. Dahlen, G. Hedlund, and K. Dawe
Low CD86 Expression in the Nonobese Diabetic Mouse Results in the Impairment of Both T Cell Activation and CTLA-4 Up-Regulation
J. Immunol., March 1, 2000; 164(5): 2444 - 2456.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Lejon C. and G. Fathman
Isolation of Self Antigen-Reactive Cells from Inflamed Islets of Nonobese Diabetic Mice Using CD4high Expression as a Marker
J. Immunol., November 15, 1999; 163(10): 5708 - 5714.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Balasa, J. D. Davies, J. Lee, A. Good, B. T. Yeung, and N. Sarvetnick
IL-10 Impacts Autoimmune Diabetes Via a CD8+ T Cell Pathway Circumventing the Requirement for CD4+ T and B Lymphocytes
J. Immunol., October 15, 1998; 161(8): 4420 - 4427.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Dahlen, K. Dawe, L. Ohlsson, and G. Hedlund
Dendritic Cells and Macrophages Are the First and Major Producers of TNF-{alpha} in Pancreatic Islets in the Nonobese Diabetic Mouse
J. Immunol., April 1, 1998; 160(7): 3585 - 3593.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
N. Itoh, A. Imagawa, T. Hanafusa, M. Waguri, K. Yamamoto, H. Iwahashi, M. Moriwaki, H. Nakajima, J. Miyagawa, M. Namba, et al.
Requirement of Fas for the Development of Autoimmune Diabetes in Nonobese Diabetic Mice
J. Exp. Med., August 18, 1997; 186(4): 613 - 618.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
J. Katz, C Benoist, and D Mathis
T helper cell subsets in insulin-dependent diabetes
Science, May 26, 1995; 268(5214): 1185 - 1188.
[Abstract] [PDF]


Home page
ScienceHome page
J Bohme, B Schuhbaur, O Kanagawa, C Benoist, and D Mathis
MHC-linked protection from diabetes dissociated from clonal deletion of T cells
Science, July 20, 1990; 249(4966): 293 - 295.
[Abstract] [PDF]


Home page
ScienceHome page
J. Shizuru, C Taylor-Edwards, B. Banks, A. Gregory, and C. Fathman
Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes
Science, April 29, 1988; 240(4852): 659 - 662.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1987 by the American Diabetes Association.